JOINT FILING AGREEMENT
Exhibit
2
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as
amended, each of the undersigned Reporting Persons hereby agrees to the joint
filing, along with all other such Reporting Persons, on behalf of each of them
of a statement on Schedule 13D (including amendments thereto) with respect to
shares of Common Stock, $0.01 par value per share, of ENDO Pharmaceuticals
Holdings Inc., and that this Agreement be included as an Exhibit to such joint
filing. This Agreement may be executed in any number of counterparts,
all of which taken together shall constitute one and the same
instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this Agreement as of
this 17th day of February, 2009.
|
||
By:
|
/s/
Xxxxxxxx Xxxxx
|
|
Xxxxxxxx
Xxxxx
|
||
Authorized
Signatory
|
X.
X. XXXX & CO., L.P.
|
|
By:
|
/s/
Xxxxxxxx Xxxxx
|
Xxxxxxxx
Xxxxx
|
|
Chief
Compliance Officer
|
XXXXX
X. XXXX
|
|
By:
|
/s/
Xxxxxxxx Xxxxx
|
Xxxxxxxx
Xxxxx
|
|
Attorney-in-Fact
for Xxxxx X. Xxxx
|